Modulation of epithelial tight junctions by TGF-beta 3 in cultured oral epithelial cells

Australian Dental Journal

Volumn 57, Issue 1, 2012, Pages 11-17

  Ye, P ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

epithelial barrier; periodontitis; Src kinase inhibitor saracatinib (AZD0530); TGF 3; tight junction protein

Indexed keywords

1,3 BENZODIOXOLE DERIVATIVE; CELL ADHESION MOLECULE; CLAUDIN; CSK TYROSINE PROTEIN KINASE; CSK TYROSINE-PROTEIN KINASE; MEMBRANE PROTEIN; N (5 CHLORO 1,3 BENZODIOXOL 4 YL) 7 (2 (4 METHYLPIPERAZIN 1 YL)ETHOXY) 5 (TETRAHYDRO 2H PYRAN 4 YLOXY)QUINAZOLIN 4 AMINE; N-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-7-(2-(4-METHYLPIPERAZIN-1-YL)ETHOXY)-5-(TETRAHYDRO-2H-PYRAN-4-YLOXY)QUINAZOLIN-4-AMINE; OCCLUDIN; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE; QUINAZOLINE DERIVATIVE; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA3;

ARTICLE; BIOSYNTHESIS; CELL MEMBRANE PERMEABILITY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; EPITHELIUM CELL; GENE EXPRESSION PROFILING; GENETICS; GINGIVA; HUMAN; METABOLISM; PATHOLOGY; PERIODONTAL POCKET; PHYSIOLOGY; TIGHT JUNCTION; TUMOR CELL LINE;

BENZODIOXOLES; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL MEMBRANE PERMEABILITY; CLAUDINS; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; GINGIVA; HUMANS; MEMBRANE PROTEINS; PERIODONTAL POCKET; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; QUINAZOLINES; RECOMBINANT PROTEINS; TIGHT JUNCTIONS; TRANSFORMING GROWTH FACTOR BETA3;

EID: 84857732761     PISSN: 00450421     EISSN: 18347819     Source Type: Journal    
DOI: 10.1111/j.1834-7819.2011.01651.x     Document Type: Article

References (15)

1. Ye P, Chapple CC, Kumar RK, Hunter N,. Expression patterns of E-cadherin, involucrin, and connexin gap junction proteins in the lining epithelia of inflamed gingiva. J Pathol 2000; 192: 58-66.
2. Hunter N, Nicholls B, Srivastava M, Chapple CC, Zoellner HF, Gibbins JR,. Reactive pocket epithelium in untreated chronic periodontal disease: possible derivation from developmental remnants of the enamel organ and root sheath. J Oral Pathol Med 2001; 30: 178-186. (Pubitemid 32139989)
3. Ye P, Simonian M, Chapple CC, Gibbins JR, Kumar RK, Hunter N,. Differential expression of transforming growth factors-beta 1, -beta 2, -beta 3 and the type I, II, III receptors in the lining epithelia of inflamed gingiva. Pathology 2003; 35: 384-392. (Pubitemid 37310978)
4. Ye P, Simonian M, Nadkarni MA, Decarlo AA, Chapple CC, Hunter N,. Identification of epithelial auto-antigens associated with periodontal disease. Clin Exp Immunol 2005; 139: 328-337. (Pubitemid 40222851)
5. Ye P, Nadkarni MA, Hunter N,. Regulation of E-cadherin and TGF-beta3 expression by CD24 in cultured oral epithelial cells. Biochem Biophys Res Commun 2006; 349: 229-235. (Pubitemid 44331786)
6. Ye P, Nadkarni MA, Simonian M, Hunter N,. CD24 regulated gene expression and distribution of tight junction proteins is associated with altered barrier function in oral epithelial monolayers. BMC Cell Biol 2009; 10: 2.
7. Prime SS, Nixon SV, Crane IJ, et al., The behaviour of human oral squamous cell carcinoma in cell culture. J Pathol 1990; 160: 259-269. (Pubitemid 20115509)
8. Swierenga SH, MacManus JP,. Preparation of low calcium growth medium suitable for determination of tumorigenicity of cultured cells. J Tissue Culture Methods 1982; 7: 1-3. (Pubitemid 13065864)
9. Wang H, Wang Q, Pape UJ, Shen B, Huang J, Wu B, Li X,. Systematic investigation of global coordination among mRNA and protein in cellular society. BMC Genomics 2010; 11: 364.
10. Atfi A, Drobetsky E, Boissonneault M, Chapdelaine A, Chevalier S,. Transforming growth factor beta down-regulates Src family protein tyrosine kinase signaling pathways. J Biol Chem 1994; 269: 30688-30693. (Pubitemid 24376558)
11. Park SS, Eom YW, Kim EH, et al., Involvement of c-Src kinase in the regulation of TGF-beta1-induced apoptosis. Oncogene 2004; 23: 6272-6281.
12. Miyazono K,. Positive and negative regulation of TGF-beta signaling. J Cell Sci 2000; 113: 1101-1109. (Pubitemid 30229527)
13. Hannon RA, Clack G, Rimmer M, et al., Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: a randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trial. J Bone Miner Res 2010; 25: 463-471.
14. Huh MI, Chang Y, Jung JC,. Temporal and spatial distribution of TGF-beta isoforms and signaling intermediates in corneal regenerative wound repair. Histol Histopathol 2009; 24: 1405-1416.
15. Ahmed S, Liu CC, Nawshad A,. Mechanisms of palatal epithelial seam disintegration by transforming growth factor (TGF) beta3. Dev Biol 2007; 309: 193-207. (Pubitemid 47361107)